A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease
dc.rights.license | open | en_US |
dc.contributor.author | ENGELHARDT, J. | |
dc.contributor.author | CAIRE, F. | |
dc.contributor.author | DAMON-PERRIERE, N. | |
dc.contributor.author | GUEHL, D. | |
dc.contributor.author | BRANCHARD, O. | |
dc.contributor.author | AUZOU, N. | |
dc.contributor.author | TISON, F. | |
dc.contributor.author | MEISSNER, W. G. | |
dc.contributor.author | KRIM, E. | |
dc.contributor.author | BANNIER, S. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | BENARD, Antoine | |
dc.contributor.author | SITTA, R. | |
dc.contributor.author | FONTAINE, D. | |
dc.contributor.author | HOARAU, X. | |
dc.contributor.author | BURBAUD, P. | |
dc.contributor.author | CUNY, E. | |
dc.date.accessioned | 2021-03-15T15:43:35Z | |
dc.date.available | 2021-03-15T15:43:35Z | |
dc.date.issued | 2020-11-30 | |
dc.identifier.issn | 1423-0372 (Electronic) 1011-6125 (Linking) | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/26670 | |
dc.description.abstractEn | OBJECTIVE: Asleep deep brain stimulation (DBS) for Parkinson's disease (PD) is being performed more frequently; however, motor outcomes and safety of asleep DBS have never been assessed in a prospective randomized trial. METHODS: We conducted a prospective, randomized, noncomparative trial to assess the motor outcomes of asleep DBS. Leads were implanted in the subthalamic nucleus (STN) according to probabilistic stereotactic coordinates with a surgical robot under O-arm© imaging guidance under either general anesthesia without microelectrode recordings (MER) (20 patients, asleep group) or local anesthesia with MER and clinical testing (9 patients, awake group). RESULTS: The mean motor improvement rates on the Unified Parkinson's Disease Rating Scale Part III (UPDRS-3) between OFF and ON stimulation without medication were 52.3% (95% CI: 45.4-59.2%) in the asleep group and 47.0% (95% CI: 23.8-70.2%) in the awake group, 6 months after surgery. Except for a subcutaneous hematoma, we did not observe any complications related to the surgery. Three patients (33%) in the awake group and 8 in the asleep group (40%) had at least one side effect potentially linked with neurostimulation. CONCLUSIONS: Owing to its randomized design, our study supports the hypothesis that motor outcomes after asleep STN-DBS in PD may be noninferior to the standard awake procedure. | |
dc.language.iso | EN | en_US |
dc.title.en | A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease | |
dc.title.alternative | Stereotact Funct Neurosurg | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1159/000511424 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 33254172 | en_US |
bordeaux.journal | Stereotactic and Functional Neurosurgery | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | PharmacoEpi-Drugs | en_US |
bordeaux.team | USMR | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-03169821 | |
hal.version | 1 | |
hal.date.transferred | 2021-03-15T15:43:39Z | |
hal.export | true | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Stereotactic%20and%20Functional%20Neurosurgery&rft.date=2020-11-30&rft.eissn=1423-0372%20(Electronic)%201011-6125%20(Linking)&rft.issn=1423-0372%20(Electronic)%201011-6125%20(Linking)&rft.au=ENGELHARDT,%20J.&CAIRE,%20F.&DAMON-PERRIERE,%20N.&GUEHL,%20D.&BRANCHARD,%20O.&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |